Author

Andrew Garven

Queen's UniversityORCID 0009-0009-2274-5840Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Approach:deep learning· 1

Frequent Co-Authors

David Monty BermaniD· 4 shared Amber L. SimpsoniD· 3 shared Madhuri KotiiD· 3 shared Andrew W. CraigiD· 2 shared Charles H. GrahamiD· 2 shared Kathrin TyryshkiniD· 2 shared Lynne-Marie M PostovitiD· 2 shared Peter A. GreeriD· 2 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

David Monty BermanORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 10, 2026

Failure of Bacillus Calmette-Guerin Therapy in Patients with Bladder Cancer is Characterized by Immune Dysfunction Associated with Activator Protein 1

Andrew Garven, Jean‐François Paré, Alexandra Robins…·Charles H. Graham

This study identifies immune dysfunction linked to AP-1 in BCG non-responders with NMIBC, suggesting pre-existing immunosenescence contributes to early recurrence.

DOI 10.64898/2026.05.06.723215

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 3, 2025

Cell State Chaos Underpins the Evolution of SMARCA4-Deficient Dedifferentiated Endometrial Cancer

Mackenzie Brandon‐Coatham, Julia Avian Vassalakis, Hannah Plummer…·Lynne-Marie M Postovit

This study shows that SMARCA4 loss in endometrial cancer leads to cell state chaos, not stemness, causing dedifferentiation through epigenomic dysregulation.

DOI 10.64898/2025.12.01.690470

mousescRNA-seq

𝕏 PostBluesky

ImmunologyCancer ResearchPeer-reviewedApr 29, 2025

Fes-deficient macrophages enhance CD8+ T cell priming and tumour control through increased proinflammatory cytokine production and localization

Brian J. Laight, Danielle Harper, Natasha Dmytryk…·Peter A. Greer

3 citations

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 19, 2023

Increased stromal densities of B cells, CD103+ cells, and CD163+ M2-like macrophages associate with poor clinical outcomes in BCG treated non-muscle invasive bladder cancer

Benjamin Ravenscroft, Priyanka Yolmo, Stephen W. Chenard…·Madhuri Koti

This study identifies increased stromal densities of B cells, CD103+ cells, and CD163+ M2-like macrophages as predictors of poor clinical outcomes in BCG-treated NMIBC patients.

1 citation

humanimaging

𝕏 PostBluesky